Response to Katona et al

Mok Oh¹, Ali McBride², Seongseok Yun³, Sandipan Bhattacharjee⁴, Marion Slack⁴, Jennifer R Martin⁵, Joanne Jeter⁶, Ivo Abraham^{4

7

8}

Affiliations

¹ Department of Pharmacy Practice and Science, College of Pharmacy, Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, Tucson, AZ.
² Department of Pharmacy Practice and Science, College of Pharmacy, Banner University Medical Center, University of Arizona Cancer Center, Tucson, AZ.
³ Malignant Hematology Department, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL.
⁴ Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ.
⁵ Arizona Health Sciences Library, Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ.
⁶ Departments of Human Genetics and Medical Oncology, College of Medicine, The Ohio State University, Columbus, OH.
⁷ Department of Human Genetics and Medical Oncology, Center for Health Outcomes and PharmacoEconomic Research, University of Arizona Cancer Center, University of Arizona, Tucson, AZ.
⁸ Department of Family and Community Medicine, College of Medicine - Tucson, University of Arizona, Tucson, AZ.

Comment

Mok Oh et al. J Natl Cancer Inst. 2019.

. 2019 May 1;111(5):524-525.

doi: 10.1093/jnci/djz013.

Mok Oh¹, Ali McBride², Seongseok Yun³, Sandipan Bhattacharjee⁴, Marion Slack⁴, Jennifer R Martin⁵, Joanne Jeter⁶, Ivo Abraham^{4

7

8}

¹ Department of Pharmacy Practice and Science, College of Pharmacy, Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, Tucson, AZ.
² Department of Pharmacy Practice and Science, College of Pharmacy, Banner University Medical Center, University of Arizona Cancer Center, Tucson, AZ.
³ Malignant Hematology Department, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL.
⁴ Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ.
⁵ Arizona Health Sciences Library, Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ.
⁶ Departments of Human Genetics and Medical Oncology, College of Medicine, The Ohio State University, Columbus, OH.
⁷ Department of Human Genetics and Medical Oncology, Center for Health Outcomes and PharmacoEconomic Research, University of Arizona Cancer Center, University of Arizona, Tucson, AZ.
⁸ Department of Family and Community Medicine, College of Medicine - Tucson, University of Arizona, Tucson, AZ.

No abstract available

Comment on

BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis.
Oh M, McBride A, Yun S, Bhattacharjee S, Slack M, Martin JR, Jeter J, Abraham I. Oh M, et al. J Natl Cancer Inst. 2018 Nov 1;110(11):1178-1189. doi: 10.1093/jnci/djy148. J Natl Cancer Inst. 2018. PMID: 30380096
RE: BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis.
Katona BW, Stadler ZK, Robson ME, Domchek SM. Katona BW, et al. J Natl Cancer Inst. 2019 May 1;111(5):522-523. doi: 10.1093/jnci/djz012. J Natl Cancer Inst. 2019. PMID: 30715414 Free PMC article. No abstract available.